Fatal X-linked lymphoproliferative disease type 1-associated limbic encephalitis with positive anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antibody.

MLA

Ochiai, Satoru, et al. “Fatal X-Linked Lymphoproliferative Disease Type 1-Associated Limbic Encephalitis with Positive Anti-Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Antibody.” Brain & Development, vol. 44, no. 9, Oct. 2022, pp. 630–34. EBSCOhost, https://doi.org/10.1016/j.braindev.2022.06.004.

APA

Ochiai, S., Hayakawa, I., Ohashi, E., Hamano, S., Miyata, Y., Sakuma, H., Hogetsu, K., Gocho, Y., Ogura, M., Uchiyama, T., & Abe, Y. (2022). Fatal X-linked lymphoproliferative disease type 1-associated limbic encephalitis with positive anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antibody. Brain & Development, 44(9), 630–634. https://doi.org/10.1016/j.braindev.2022.06.004

Chicago

Ochiai, Satoru, Itaru Hayakawa, Eri Ohashi, Sho Hamano, Yohane Miyata, Hiroshi Sakuma, Keita Hogetsu, et al. 2022. “Fatal X-Linked Lymphoproliferative Disease Type 1-Associated Limbic Encephalitis with Positive Anti-Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Antibody.” Brain & Development 44 (9): 630–34. doi:10.1016/j.braindev.2022.06.004.